S&P 500

5.247,78

-0,56%

Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Verrica Parmaceuticals Inc (VRCA)
Verrica Parmaceuticals Inc (VRCA) Notícias

VRCA

Verrica Parmaceuticals (VRCA)

Verrica Parmaceuticals Inc

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:VRCA

1 2 3 4 5 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
15/05/2024	08:45	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VRCA	Verrica Parmaceuticals Inc
13/05/2024	17:31	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:VRCA	Verrica Parmaceuticals Inc
13/05/2024	09:01	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:VRCA	Verrica Parmaceuticals Inc
29/02/2024	10:05	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:VRCA	Verrica Parmaceuticals Inc
16/11/2023	18:49	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VRCA	Verrica Parmaceuticals Inc
16/11/2023	12:28	Edgar (US Regulatory)	Form 144/A - Report of proposed sale of securities: [Amend]	NASDAQ:VRCA	Verrica Parmaceuticals Inc
15/11/2023	18:54	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:VRCA	Verrica Parmaceuticals Inc
21/07/2023	20:28	Dow Jones News	Stocks to Watch: AMC Entertainment, Becton Dickinson and Verrica Pharmaceuticals	NASDAQ:VRCA	Verrica Parmaceuticals Inc
21/07/2023	18:05	Dow Jones News	Verrica Pharmaceuticals' Molluscum Contagiosum Topical Solution Gets FDA Approval	NASDAQ:VRCA	Verrica Parmaceuticals Inc
12/06/2023	10:05	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VRCA	Verrica Parmaceuticals Inc
08/06/2023	17:17	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:VRCA	Verrica Parmaceuticals Inc
09/05/2023	09:28	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:VRCA	Verrica Parmaceuticals Inc
09/05/2023	09:22	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:VRCA	Verrica Parmaceuticals Inc
21/04/2023	09:57	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:VRCA	Verrica Parmaceuticals Inc
21/04/2023	09:51	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:VRCA	Verrica Parmaceuticals Inc
21/04/2023	09:46	Edgar (US Regulatory)	Annual Report to Security Holders (ars)	NASDAQ:VRCA	Verrica Parmaceuticals Inc
06/03/2023	11:41	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:VRCA	Verrica Parmaceuticals Inc
22/02/2023	18:18	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:VRCA	Verrica Parmaceuticals Inc
14/02/2023	16:37	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:VRCA	Verrica Parmaceuticals Inc
20/12/2022	08:10	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:VRCA	Verrica Parmaceuticals Inc
14/11/2022	08:15	TipRanks	H.C. Wainwright Remains a Buy on Verrica Pharmaceuticals (VRCA)	NASDAQ:VRCA	Verrica Parmaceuticals Inc
10/11/2022	22:48	TipRanks	RBC Capital Remains a Hold on Verrica Pharmaceuticals (VRCA)	NASDAQ:VRCA	Verrica Parmaceuticals Inc
07/11/2022	19:23	Edgar (US Regulatory)	Securities Registration Statement (simplified Form) (s-3)	NASDAQ:VRCA	Verrica Parmaceuticals Inc
07/11/2022	18:05	GlobeNewswire Inc.	Verrica Pharmaceuticals Reports Third Quarter 2022 Financial Results	NASDAQ:VRCA	Verrica Parmaceuticals Inc
31/08/2022	17:30	GlobeNewswire Inc.	Verrica Pharmaceuticals Announces Participation in the H.C. Wainwright 24th Annual Global Investment Conference	NASDAQ:VRCA	Verrica Parmaceuticals Inc
12/08/2022	07:25	TipRanks	H.C. Wainwright Keeps Their Buy Rating on Verrica Pharmaceuticals (VRCA)	NASDAQ:VRCA	Verrica Parmaceuticals Inc
11/08/2022	17:35	TipRanks	Needham Remains a Hold on Verrica Pharmaceuticals (VRCA)	NASDAQ:VRCA	Verrica Parmaceuticals Inc
11/08/2022	08:30	GlobeNewswire Inc.	Verrica Pharmaceuticals Reports Second Quarter 2022 Financial Results	NASDAQ:VRCA	Verrica Parmaceuticals Inc
05/08/2022	13:18	PR Newswire (US)	VRCA SHAREHOLDER ALERT: Jakubowitz Law Reminds Verrica Shareholders of a Lead Plaintiff Deadline of August 5, 2022	NASDAQ:VRCA	Verrica Parmaceuticals Inc
03/08/2022	06:45	PR Newswire (US)	SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Verrica Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 5, 2022 - (NASDAQ: VRCA)	NASDAQ:VRCA	Verrica Parmaceuticals Inc